BofA Securities Starts Werewolf Therapeutics Inc. (HOWL) at Buy (Earlier)
Tweet
Share
E-mailGet Alerts HOWL Hot Sheet
Price: $0.40 --0%
Rating Summary:
5 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 10 | New: 16
Rating Summary:
5 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 10 | New: 16
Join SI Premium – FREE
BofA Securities analyst Jason Zemansky initiates coverage on Werewolf Therapeutics Inc. (NASDAQ: HOWL) with a Buy rating and a price target of $26.00.
The firm said the company's differentiated PREDATOR platform sets it apart from an expanding field of next-gen I/O developers.
For an analyst ratings summary and ratings history on Werewolf Therapeutics Inc. click here. For more ratings news on Werewolf Therapeutics Inc. click here.
Shares of Werewolf Therapeutics Inc. closed at $17.50 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BMO Capital Resumes Global Net Lease (GNL), Upgrades to Outperform
- ICICI Securities Downgrades Manappuram Finance Ltd (MGFL:IN) to Hold (3)
- Piper Sandler Starts SoFi Technologies (SOFI) at Overweight
Create E-mail Alert Related Categories
Analyst Comments, New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
